Zebrafish Models for Dyslipidemia and Atherosclerosis Research

Frontiers in Endocrinology - Switzerland
doi 10.3389/fendo.2016.00159
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2012English

Effect of standardizedAmlaextract on Atherosclerosis and Dyslipidemia

Indian Journal of Pharmaceutical Sciences
Pharmaceutical Science
2006English

Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2003English

Advances in Dyslipidemia Management for Prevention of Atherosclerosis: PCSK9 Monoclonal Antibody Therapy and Beyond

Cardiovascular Diagnosis and Therapy
Cardiovascular MedicineCardiology
2017English

Ces3/TGH Deficiency Improves Dyslipidemia and Reduces Atherosclerosis in LDLR-/- Mice

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2012English

A Novel Swine Model for Evaluation of Dyslipidemia and Atherosclerosis Induced by Human CETP Overexpression

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2017English

Monocyte DPP4 Expression in Human Atherosclerosis Is Associated With Obesity and Dyslipidemia

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

Zebrafish Aging Models and Possible Interventions

2018English

Dyslipidemia-Associated Alterations in B Cell Subpopulation Frequency and Phenotype During Experimental Atherosclerosis

Atherosclerosis
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy